Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP371815.RA7E_izzOek1uLMzJ8V9krKKJLqBLJV4e7IIw4mp1ZnGM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP371815.RA7E_izzOek1uLMzJ8V9krKKJLqBLJV4e7IIw4mp1ZnGM130_assertion type Assertion NP371815.RA7E_izzOek1uLMzJ8V9krKKJLqBLJV4e7IIw4mp1ZnGM130_head.
- NP371815.RA7E_izzOek1uLMzJ8V9krKKJLqBLJV4e7IIw4mp1ZnGM130_assertion description "[Association between the treatment length and cumulative dose of pegylated interferon alpha-2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: project of the Kyushu University Liver Disease Study Group.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP371815.RA7E_izzOek1uLMzJ8V9krKKJLqBLJV4e7IIw4mp1ZnGM130_provenance.
- NP371815.RA7E_izzOek1uLMzJ8V9krKKJLqBLJV4e7IIw4mp1ZnGM130_assertion evidence source_evidence_literature NP371815.RA7E_izzOek1uLMzJ8V9krKKJLqBLJV4e7IIw4mp1ZnGM130_provenance.
- NP371815.RA7E_izzOek1uLMzJ8V9krKKJLqBLJV4e7IIw4mp1ZnGM130_assertion SIO_000772 18248381 NP371815.RA7E_izzOek1uLMzJ8V9krKKJLqBLJV4e7IIw4mp1ZnGM130_provenance.
- NP371815.RA7E_izzOek1uLMzJ8V9krKKJLqBLJV4e7IIw4mp1ZnGM130_assertion wasDerivedFrom befree-20140225 NP371815.RA7E_izzOek1uLMzJ8V9krKKJLqBLJV4e7IIw4mp1ZnGM130_provenance.
- NP371815.RA7E_izzOek1uLMzJ8V9krKKJLqBLJV4e7IIw4mp1ZnGM130_assertion wasGeneratedBy ECO_0000203 NP371815.RA7E_izzOek1uLMzJ8V9krKKJLqBLJV4e7IIw4mp1ZnGM130_provenance.